Attached files
file | filename |
---|---|
EX-99.1 - PEDIATRX, INC. PRESS RELEASE DATED APRIL 6, 2011 - THERALINK TECHNOLOGIES, INC. | exhibit99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of
1934
Date of Report (Date of earliest event reported) April 6,
2011
PEDIATRX
INC.
(Exact name of registrant as specified in its
charter)
Nevada | 000-52218 | 20-2590810 |
(State or other jurisdiction of | (Commission File Number) | (IRS Employer Identification No.) |
incorporation) |
405 Trimmer Road, Suite 200, Califon, NJ | 07830 |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code (908)
975-0753
N/A
(Former name or former
address, if changed since last report.)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions:
[
] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a
-12)
[ ] Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[
] Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 8.01 | Other Events. |
A copy of our press release dated April 6, 2011 is furnished herewith.
Item 9.01 | Financial Statements and Exhibits. |
(d) | Exhibits. |
99.1 | PediatRx, Inc. Press Release dated April 6, 2011 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PEDIATRX INC.
Cameron Durrant
Cameron
Durrant
President, Chief Executive Officer and Director
Date: April 6, 2011